Ishibe T
Urol Int. 1977;32(5):393-400. doi: 10.1159/000280156.
In patients with various genitourinary neoplasms, except in those with untreated bladder carcinoma, changes of SLDH and SLDH-V fraction levels owing to hyperglycemic conditions were statistically not significant to the pretreatment levels. In patients with untreated bladder carcinoma, the levels after 48 h were statistically significantly lower than the pretreatment levels. However, these decreases disappeared after radical treatment. In patients having abnormally high pretreatment levels, the frequency of cases which decreased to more than 20% of their pretreatment levels was 47% for SLDH and 60% for SLDH-V. This test was useful not only as a diagnostic tool, but also as a means of predicting therapeutic results.
在患有各种泌尿生殖系统肿瘤的患者中,除了未治疗的膀胱癌患者外,高血糖状态导致的SLDH和SLDH-V分数水平变化与治疗前水平相比在统计学上无显著差异。在未治疗的膀胱癌患者中,48小时后的水平在统计学上显著低于治疗前水平。然而,这些下降在根治性治疗后消失。在治疗前水平异常高的患者中,SLDH降至治疗前水平20%以上的病例频率为47%,SLDH-V为60%。该检测不仅可用作诊断工具,还可作为预测治疗效果的手段。